Evidence map›Paper›PMID 31560857›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2019

Redistribution of EC-SOD resolves bleomycin-induced inflammation

Ayed Allawzi, Ivy McDermott, Cassidy Delaney, Kianna Nguyen, Laith Banimostafa, Ashley Trumpie, Laura Hernandez-Lagunas, Kent Riemondy, Austin Gillen, Jay Hesselberth and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Targeting the Aryl Hydrocarbon Receptor to Attenuate IGF1R Signaling in Thyroid Eye Disease.Thyroid : official journal of the American Thyroid Association · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Lactate produced by alveolar type II cells suppresses inflammatory alveolar macrophages in acute lung injury.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2023
    Article
  12. Article
  13. Article
  14. The role of lung macrophages in acute respiratory distress syndrome.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2022
    Review
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

Ayed AllawziCardiovascular Pulmonary Research Laboratories, Departments of Pediatrics and Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Ivy McDermottCardiovascular Pulmonary Research Laboratories, Departments of Pediatrics and Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Cassidy DelaneyCardiovascular Pulmonary Research Laboratories, Departments of Pediatrics and Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Kianna NguyenCardiovascular Pulmonary Research Laboratories, Departments of Pediatrics and Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Laith BanimostafaCardiovascular Pulmonary Research Laboratories, Departments of Pediatrics and Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Ashley TrumpieCardiovascular Pulmonary Research Laboratories, Departments of Pediatrics and Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Laura Hernandez-LagunasCardiovascular Pulmonary Research Laboratories, Departments of Pediatrics and Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Kent RiemondyRNA Bioscience Initiative, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Austin GillenRNA Bioscience Initiative, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Jay HesselberthRNA Bioscience Initiative, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Karim El KasmiCardiovascular Pulmonary Research Laboratories, Departments of Pediatrics and Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Carmen C SucharovDivision of Cardiology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
William J JanssenDepartment of Medicine, National Jewish Health, Denver, Colorado, USA.
Kurt StenmarkCardiovascular Pulmonary Research Laboratories, Departments of Pediatrics and Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Russell BowlerDepartment of Medicine, National Jewish Health, Denver, Colorado, USA.
Eva Nozik-GrayckCardiovascular Pulmonary Research Laboratories, Departments of Pediatrics and Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
University of Colorado Anschutz Medical Campus · USNational Jewish Health · USBoehringer Ingelheim (Germany) · DE

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
Translational Pulmonary Vascular Biology ProgramT32HL007171 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI Sonia Castro Flores, Tim Lahm · 1985 to 2026
$9.4M
Lung Macrophage Programming in Acute Lung InjuryR35HL140039 · NHLBI · NATIONAL JEWISH HEALTH · PI JANSSEN, WILLIAM · 2018 to 2024
$6.4M
Impact of Insufficient Vascular EC-SOD in Pulmonary HypertensionR01HL086680 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI NOZIK, EVA S. · 2008 to 2017
$4.7M
SOD3 regulation of redox sensitive signaling in pulmonary vascular diseasesR35HL139726 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI NOZIK, EVA S. · 2018 to 2024
$4.1M
miRNA Regulation of Vascular Permeability and Inflammation in the Lung InjuryR01HL119533 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI CARPENTER, TODD C, KOMPELLA, UDAY B · 2014 to 2017
$2.5M
Platelet-derived serotonin in neonatal pulmonary hypertensionK08HL132014 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI DELANEY, CASSIDY A · 2016 to 2019
$661k
American Heart Association-American Stroke Association 19POST34380396NCI NIH HHS P30 CA046934NHLBI NIH HHS K08 HL132014NHLBI NIH HHS R01 HL086680NHLBI NIH HHS R01 HL119533NHLBI NIH HHS R35 HL139726NHLBI NIH HHS R35 HL140039NHLBI NIH HHS T32 HL007171
6 · The paper itself

Abstract

A human single nucleotide polymorphism (SNP) in the matrix-binding domain of extracellular superoxide dismutase (EC-SOD), with arginine to glycine substitution at position 213 (R213G), redistributes EC-SOD from the matrix into extracellular fluids. We reported that, following bleomycin (bleo), knockin mice harboring the human R213G SNP (R213G mice) exhibit enhanced resolution of inflammation and protection against fibrosis, compared with wild-type (WT) littermates. In this study, we tested the hypothesis that the EC-SOD R213G SNP promotes resolution

Indexed as

ApoptosisAnimalsAntibiotics, AntineoplasticBleomycinCells, CulturedExtracellular FluidExtracellular MatrixFemaleFibrosisHumansInflammationLungMacrophages, AlveolarMiceMice, Inbred C57BLPolymorphism, Single NucleotideAntibiotics, AntineoplasticBleomycinSOD3 protein, humanSuperoxide Dismutaseacute lung injuryextracellular superoxide dismutasepulmonary fibrosisSOD3

Identifiers

PMID31560857
PMCPMC6894081
OpenAlexW2977083575

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.